Atricure IncATRC

Buy more

Buy more at today's $56, already under our buy price.

6 good· Earnings beat
3 to watch· Fewer buy ratings

$56.31−1.22 (−2.12%)

Price at 3:00 PM ET

After hours · opens in 17h 23m

NASDAQ · Healthcare · Mid-size company

Tell me when ATRC moves 5% in a day

The price we'd buy ATRC at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

From the 10-Q for the quarter to Sep 30, reported Nov 3
Yahoo Finance daily closes to Nov 9

Any one could move it to Keep

Next report

below7%
sales growth

Compared with the S&P 500

10 points
worse in one day
23 points
worse in five trading days

+76.0% in a yearsince Nov 10, 2025

Earnings report

Latest results

Reported Nov 3 after the close

EPS: $0.17; vs $0.01 expected, beat by $0.16 a share
The stock: +8.5%; On Nov 4, usually 6.2%

The news behind our call

written Oct 27, 3:12 AM ETOct 27, 3:12 AM ET · 1 articles · 1 sources

AtriCure will present at two healthcare investor conferences in November.
Most covering analysts rate AtriCure positively.

What changed

From Yahoo Finance and Atricure Inc via Yahoo Finance

What AtriCure (ATRC) said on its Q3 earnings call
Nov 3
ATRC reported earnings
Earnings · Nov 3
AtriCure reports Third quarter 2026 Financial results
Nov 3
Analyst ratings shifted: 1 fewer buy, 1 more hold
7 buy, 3 hold, 0 sell, against 8 buy, 2 hold, 0 sell the month before.
Analysts · Last month
AtriCure to Participate at upcoming investor Conferences
Oct 26
Gilbert Cisneros sold ATRC
House, D-CA. Amount $1K to $15K.
Congress · Sep 29
Gilbert Cisneros bought ATRC
House, D-CA. Amount $1K to $15K.
Congress · Aug 20

Overview

In plain numbers

Revenue grew 13.8% from a year earlier, to $589.8M in the last twelve months.
It keeps 3 cents of every revenue dollar as operating profit, up from a loss of 17 cents in FY 2021.
It turned 9% of revenue into free cash flow: $52.9M in the last twelve months.
It holds $187.0M in cash and investments against $96.8M of debt, which leaves $90.2M of net cash.

Key figures

Revenue (TTM): $590M
Revenue growth, 1 year: +13.8%
Net income: $14.9M
EPS (diluted): $0.31
Gross margin: 76.7%
Operating margin: 2.9%

Return on equity: 3.0%
Return on capital: 3.6%
Debt / equity: 0.18
Current ratio: 4.33
Buyback yield: -3.13%

Key facts

Company value: $3.0B
Price / last year's earnings: 290.9×
Today's range: 56.2458.24

Past year's range: 25.8665.53
Yesterday's close: $57.53
Swings vs the market: 1.3×about the same